ProAssurance Corporation (PRA)

Currency in USD
25.00
0.00(0.00%)
Closed·
Showing ProAssurance historical data. For real-time data please try another search
Fair Value
Day's Range
24.9925.01
52 wk Range
22.7925.02
Key Statistics
Prev. Close
25
Open
25
Day's Range
24.99-25.01
52 wk Range
22.79-25.02
Volume
3.38M
Average Volume (3m)
1.03M
1-Year Change
9.505%
Book Value / Share
26.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.00
Upside
0.00%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

ProAssurance Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

0 Buy
3 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 25.00
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

ProAssurance Corporation SWOT Analysis


Financial Resilience
ProAssurance outperforms expectations with Q2 2024 EPS of $0.23, showcasing strong financial health and market positioning despite industry challenges
Strategic Discipline
Delve into ProAssurance's commitment to underwriting discipline and pricing strategy, balancing profitability with market competitiveness in key segments
Market Headwinds
Explore how ProAssurance navigates industry-wide challenges, including large jury verdicts and severity inflation, while maintaining a cautious growth approach
Future Prospects
Analysts project a $20 price target, with potential for accelerated book value growth through share repurchases and improved profitability as pricing actions take effect
Read full SWOT analysis

ProAssurance Corporation Earnings Call Summary for Q4/2024

  • ProAssurance Q4 2024 EPS at $0.36, doubling $0.18 forecast; revenue of $290.1M beat expectations by $61.68M
  • Stock surged 16.58% post-earnings to $16.45, approaching 52-week high of $17.79; company maintains profitability
  • Net investment income up 9% for quarter; book value per share rose to $23.49; strong liquidity with 2.15x current ratio
  • Company focuses on rate adequacy, cautious investment expansion; expects continued rate push in specialty P&C, workers' comp
  • Challenges persist in medical liability legal environment; social inflation and market competition remain concerns
Last Updated: 2025-02-25, 10:56 a/m
Read Full Transcript

Earnings

Latest Release
May 05, 2026
EPS / Forecast
0.25 / 0.27
Revenue / Forecast
262.63M / 213.85M
EPS Revisions
Last 90 days

PRA Income Statement

Compare PRA to Peers and Sector

Metrics to compare
PRA
Peers
Sector
Relationship
P/E Ratio
19.8x10.7x10.1x
PEG Ratio
0.380.220.03
Price/Book
1.0x1.8x1.0x
Price / LTM Sales
1.2x1.3x2.9x
Upside (Analyst Target)
0.0%0.1%12.6%
Fair Value Upside
Unlock3.1%1.7%Unlock

People Also Watch

24.490
SPNT
-0.24%
13.98
AESI
+1.16%
78.28
PHIN
-1.76%
24.05
INVX
+1.86%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.